Ian David Aronson
Overview
Explore the profile of Ian David Aronson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aronson I, Ardouin-Guerrier M, Baus J, Bennett A
JMIR Form Res
. 2024 Jul;
8:e56755.
PMID: 38959505
Background: Overdose deaths continue to reach new records in New York City and nationwide, largely driven by adulterants such as fentanyl and xylazine in the illicit drug supply. Unknowingly consuming...
2.
Aronson I, Bennett A, Ardouin-Guerrier M, Rivera-Castellar G, Gibson B, Vargas-Estrella B
Front Digit Health
. 2022 Nov;
4:992519.
PMID: 36339513
Technology-based behavioral health interventions offer potentially limitless opportunities to localize content and target specific populations. However, this ability to customize requires developers to make a wide range of decisions not...
3.
Aronson I, Bennett A, Ardouin-Guerrier M, Rivera-Castellar G, Gibson B, Santoscoy S, et al.
JMIR Form Res
. 2022 Feb;
6(3):e35066.
PMID: 35191841
Background: People who inject drugs are disproportionately impacted by SARS-CoV-2 and COVID-19, yet they do not frequently accept vaccination against SARS-CoV-2 when offered. Objective: This study aimed to explore why...
4.
Aronson I, Zhang J, Rajan S
Int J Health Promot Educ
. 2022 Feb;
59(6):354-365.
PMID: 35173555
Although the Centers for Disease Control and Prevention recommends routine HIV testing in emergency departments and other facilities, many patients are never offered testing, and those who are offered testing...
5.
Ibitoye M, Bennett A, Bugaghis M, Chernick L, Des Jarlais D, Aronson I
Behav Med
. 2021 Dec;
49(2):204-211.
PMID: 34965832
HIV testing rates among US youth aged 13-24 years are sub-optimal, with high rates of missed testing opportunities in emergency departments (EDs). We assessed barriers to routine HIV testing of...
6.
Aronson I, Zhang J, Rajan S, Marsch L, Bugaighis M, Ibitoye M, et al.
AIDS Behav
. 2021 Oct;
26(5):1544-1551.
PMID: 34705152
Despite federal guidelines, many adolescents and emerging adults are not offered HIV testing by their healthcare providers. As such, many-including those who may be at high-risk for contracting HIV given...
7.
Bennett A, Freeman R, Des Jarlais D, Aronson I
JMIR Form Res
. 2020 Dec;
4(12):e22411.
PMID: 33355094
Background: Many people use opioids and are at risk of overdose. Naloxone is an opioid antagonist used to counter the effects of opioid overdose. There is an increased availability of...
8.
Ibitoye M, Lappen H, Freeman R, Jordan A, Aronson I
AIDS Behav
. 2020 Nov;
25(6):1829-1838.
PMID: 33231846
HIV testing rates remain low among youth ages 13-24 in the US, with only 55% of HIV-positive youth aware of their serostatus. We conducted a systematic review to assess the...
9.
Aronson I, Bennett A, Freeman R
Harm Reduct J
. 2020 Oct;
17(1):77.
PMID: 33076911
Background: Technology can enable syringe service programs (SSPs) and other community-based organizations (CBOs) operating under a harm reduction framework to work with an increased number of clients and can also...
10.
Bennett A, Aronson I, Guarino H, Bania T, Marsch L
MMHealth16 (2016)
. 2019 Feb;
2016:41-43.
PMID: 30740604
The current paper reports on a study examining the use of a tablet-based multimedia intervention to increase HIV test rates among patients in a New York City hospital Emergency Department...